期刊文献+

Oct-4在非小细胞肺癌组织中的表达及意义 被引量:4

Expression and significance of Oct-4 in non-small cell lung cancer
下载PDF
导出
摘要 目的分析Oct-4在非小细胞肺癌(NSCLC)组织中的表达特点及规律,探讨Oct-4的表达在NSCLC发生、发展中的意义及其与肿瘤干细胞的关系。方法采用免疫组化SP法检测Oct-4蛋白在135例NSCLC组织和20例正常对照肺组织中的表达情况。结果 NSCLC组织中Oct-4表达的阳性率明显高于正常对照肺组织,二者之间的差异具有显著性(P<0.05)。Oct-4表达的阳性率与NSCLC患者的临床分期、有无淋巴结转移及肿瘤分化程度有关(P<0.01),而与患者的性别、年龄及NSCLC的组织学类型无关(P>0.05)。结论 Oct-4的表达与NSCLC的分化程度、临床分期和淋巴结转移有关,提示Oct-4的表达在NSCLC发生、发展中的可能具有一定的意义,表达Oct-4的肿瘤细胞很可能是肿瘤干细胞,推测Oct-4有可能成为分离和鉴定NSCLC肿瘤干细胞的标志物。 Objective To analyze the expression of Oct--4 in non--small lung cancer (NSCLC), explore its significance in the formation and development of NSCLC and demonstrate its relationship with cancer stem cells. Methods Immunohistochemical detection of Oct--4 was performed in 135 cases of NSCLC and 20 cases of normal lung tissue. Results The expression of Oct--4 was significantly different between NSCLC and normal lung tissue (P 〈 0.05). The expression of Oct--4 was related with clinical stage, lymph node metastasis and tumor pathological stage (P 〈 0.01), but was not related with sex, age and histological classification (P 〉0.05). Conclusions The expression of Oct--4 was related with clinical stage, lymph node metastasis and tumor pathological stage; it suggested that the expression of Oct--4 might be associated with the formation and development of NSCLC. Cells which expressed Oct-- 4 might be the tumor stem cells and Oct--4 might he the marker to isolation and identification of cancer stem cells in NSCLC.
出处 《齐齐哈尔医学院学报》 2011年第8期1204-1206,共3页 Journal of Qiqihar Medical University
基金 广州市医药卫生科技项目(2009-YB-163) 广州医学院科研基金博士启动项目(2008C06)
关键词 OCT-4 非小细胞肺癌 肿瘤干细胞 Oct--4 Non--small cell lung cancer Tumor stem cells
  • 相关文献

参考文献20

  • 1Tomida S,Yatabe Y,Yanagisawa K,et al.Throwing new light on lung cancer pathogenesis:updates on three recent topics[J].Cancer Sci,2005,96:63-68.
  • 2Jordan CT,Guzman ML,Noble M.Cancer stem cells[J].N Engl J Med,2006,355(12):1253-1261.
  • 3Neethan AL,Yohei S,Dalong Q,et al.The biology of cancer stem cells[J].Annu Rev Cell Dev Biol,2007,23:675-699.
  • 4Wicha MS,Liu SL,Dontu G.Cancer stem cells[J].Cancer Res,2006,66(4):1883-1890.
  • 5Looijenga LH,Stoop H,De Leeuw HP,et al.POU5F1(Oct3/4) identifies cells with pluripotent potential in human germ cell tumors[J].Cancer Res,2003,63(9):2244-2250.
  • 6Gupta S,Verfaillie C,Chmielewski D,et al.Isolation and characterization of kidney-derived stem cells[J].J Am Soc Nephrol,2006,23(2):20.
  • 7Suo GL,Han J,Wang X,et al.Oct4 psedogenes are transcribed in cancers[J].Biochemical and Biophysical Research Communications,2005,337(2):1047-1051.
  • 8Yu H,Fang D,Kumar SM,et al.Isolation of a novel population of multipotent adult stem cells from human hair follicles[J].Am J Pathol,2006,168(6):1879-1888.
  • 9Chen YC,Hsu HS,Chen YW,et al.Oct4 expression maintained cancer stem-like properties in lung cancer-derived CD133-positive cells[J].PLoS ONE,2008,3:e2637.
  • 10Bonnet D,Dick JE.Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell[J].Nature Med,1997,3(7):730-737.

二级参考文献16

  • 1SUMMER R, KOTTON D N, SUN X, et al. Side population cells and Bcrpl expression in lung [ J ]. Am J Physiol Lung Cell Mol Physiol, 2003, .285 ( 1 ) : L97-L104.
  • 2TAKADA T, SUZUKI H, GOTOH Y, et al. Regulation of the cell surface expression of human BCRP/ABCG2 by the phosphorylation state of Akt in polarized cells [ J ]. Drug Metab Disp, 2005, 33 ( 7 ) : 905-909.
  • 3LI L, NEAVES WB. Normal stem cells and cancer stem cells: The niche matters[ J]. Cancer Res, 2006, 66 (9) :4553-4557.
  • 4MIMEAULT M, HAUKE R, MEHTA PP, et al. Recent advances in cancer stem/progenitor cell research: therapeutic implications for overcoming resistance to the most aggressive cancers[ J]. J Cell Mol Med, 2007, 11(5) :981-1011.
  • 5BOYER L A, LEE TI, COLE M F, et al. Core transcriptional regulatory circuitry in human embryonic stem ceils [ J ]. Cell, 2005, 122(6) :947-956.
  • 6PARK I K, MORRISON S J, CLARKE M F. Bmil, stem cells, and senescence regulation [ J ]. J Clin Invest, 2004,113 ( 2 ) : 175- 179.
  • 7NAMKOONG H, SHIN SM, KIM HK, et al. The bone morphogenetic protein antagonist gremlin I is overexpressed in human cancers and interacts with YWHAN protein[ J]. BMC Cancer, 2006,6 ( 3 ) :74-86.
  • 8CLARKE M F, DICK J E, EAVES C J, et al. Cancer stem cells- perspectives on current status and future direction: AACR workshop on cancer stem ceils [ J ]. Cancer Res,2006, 66 ( 19 ) :9339- 9344.
  • 9ASSOU S, CARROUR TL, TONDEUR S, et al. A meta-analysis of human embryonic stem ceils transcriptome integrated into a web- based expression atlas [ J ]. Stem Cells, 2007, 25 (4) :961-973.
  • 10BENDALL SC, STWART MH, MENENDEZ P, et al. IGF and FGF cooperatively establish the regulatory stem cell niche of pluripotent human ceils in vitro[ J]. Nature, 2007,448(7157) :1015- 1021.

共引文献41

同被引文献51

引证文献4

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部